| Epidemiology of liver cancer in Nile delta over a decade: a single-center study S Abd-Elsalam, N Elwan, H Soliman, D Ziada, W Elkhalawany, M Salama, ... South Asian journal of cancer 7 (01), 24-26, 2018 | 84 | 2018 |
| Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study M Salama National Cancer Institute, 2016 | 82 | 2016 |
| Predictors for fibrosis regression in chronic HCV patients after the treatment with DAAS: results of a real-world cohort study H Soliman, D Ziada, M Salama, M Hamisa, R Badawi, N Hawash, A Selim, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2020 | 50 | 2020 |
| RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: A multicenter Egyptian study M El-Bendary, S Abd-Elsalam, T Elbaz, W El-Akel, A Cordie, T Elhadidy, ... Expert Review of Anti-infective Therapy 20 (2), 291-295, 2022 | 37 | 2022 |
| Autologous dendritic cells pulsed with lysate from an allogeneic hepatic cancer cell line as a treatment for patients with advanced hepatocellular carcinoma: a pilot study MTA Ghafar, MA Morad, EA El-Zamarany, D Ziada, H Soliman, ... International Immunopharmacology 82, 106375, 2020 | 28 | 2020 |
| Sofosbuvir‐containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment R Eletreby, M El‐Serafy, M Anees, G Kasem, M Salama, R Elkhouly, ... Liver International 40 (4), 797-805, 2020 | 24 | 2020 |
| The effect of HCV eradication after direct-acting antiviral agents on hepatic steatosis: a prospective observational study H Soliman, D Ziada, M Hamisa, R Badawi, N Hawash, M Salama, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2022 | 10 | 2022 |
| Serum markers as a predictor of hepatic fibrosis compared to fibroscan in chronic hepatitis B infected egyptian patients: a cross-sectional study R Badawi, H Soliman, D Ziada, M Elhendawy, S Abd-Elsalam, M Salama, ... The Open Biomarkers Journal 10 (1), 2020 | 4 | 2020 |
| Efficacy and Safety of Sofosbuvir\Ledipasvir Combination or Nitazoxanide in Treatment of COVID-19: A Placebo-Controlled, Randomized Clinical Trial M Medhat, H Karam-Allah, A Al Shafie, M Salama, DT Kamal, H Sayed, ... Journal of Hepatology, S803-S803, 2021 | | 2021 |
| 570 OUTFLOW RECONSTRUCTION USING NATIVE LIVER VEINS IN RIGHT LOBE GRAFTS WITHOUT MHV HARVESTING: 3 YEARS EXPERIENCE H Soliman, H Shoreem, T Ibrahiem, M Osman, O Hegazy, S Saleh, ... Journal of Hepatology, S232, 2011 | | 2011 |
